Top Markets
Coin of the day
WPD Pharmaceuticals Inc. WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.

WBIO
Pozycja w akcjach #34463
WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver,... WPD Pharmaceuticals Inc., a biopharmaceutical company based in Vancouver, Canada, specializes in the research and advancement of therapeutic products for oncology and infectious diseases. The company's diverse drug development pipeline features multiple promising candidates: WPD101 and WPD103 are both in pre-clinical stages, targeting brain cancers, including glioblastoma and glioblastoma multiforme respectively. Also in pre-clinical development is WPD102, aimed at Uveal Melanoma. In more advanced clinical stages, Berubicin is undergoing Phase 1 trials for glioblastoma, while WP1066, also in Phase 1 clinical trials, is being investigated for central nervous system tumors, pancreatic cancer, and ocular tumors. Additionally, the pipeline includes WP1732 for pancreatic cancer and WP1220 for cutaneous T-cell lymphoma. Annamycin is currently in Phase I/II clinical trials for acute myeloid leukemia (AML) and is also being explored for lung metastasis.
Cena akcji
$0.04895618
Ostatnia synchronizacja: 2025-03-18
Kapitalizacja rynkowa
$5.55M
Zmiana (1 dzień)
-0.04%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel WPD Pharmaceuticals Inc. (WBIO)

Kategoria

Wskaźnik P/S dla WPD Pharmaceuticals Inc. (WBIO)
Wskaźnik P/S na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji WPD Pharmaceuticals Inc., obecny wskaźnik P/S (TTM) wynosi 0. Na koniec 2026 wynosił 0.
Historia wskaźnika P/S dla WPD Pharmaceuticals Inc. od 2026 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
Za mało danych dla podanych dat.
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
10.17 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE